Relationship between renal function and cognitive impairment in patients with stable schizophrenia: A multicenter cross-sectional study
Preprint
- 21 April 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Objective Clinically stable inpatients with schizophrenia have generalized impairment of cognition function along with abnormalities in renal function, but the link between cognitive function and renal function has been underexplored. Methods This study enrolled 216 hospitalized patients with clinically stable schizophrenia. Demographic and renal function parameters were collected from electronic medical records. Cognitive function was assessed using the Chinese Brief Cognitive Test (C-BCT). To analyze the correlations between renal function and processing speed, attention, working memory, and executive function in patients hospitalized with clinically stable schizophrenia. Covariate-adjusted linear and multivariate logistic regression models were constructed to determine the relationship between renal function and cognitive function. ROC analysis was used to further investigate the prediction of renal function indices in assessing stable schizophrenia inpatients. Results Significant variations in serum Cystatin C (CysC), β2-microglobulin (β2-MG), and uric acid (UA) levels were observed among hospitalized patients with clinically stable schizophrenia across different cognitive impairment severities. Correlation analysis revealed a significant association between serum CysC levels and C-BCT scores in hospitalized patients with stable schizophrenia(β = 0.174,95%CI:0.265 ~ 1.720,p = 0.008). Particularly strong correlations were observed with processing speed T-scores(β=-0.200,95%CI:-33.446~-7.230,p = 0.03) and executive function T-scores(β=-0.171,95%CI:-17.277~-2.082, p = 0.013). Binary logistic regression analysis further confirmed that CysC may be a risk factor for exacerbation of cognitive impairment in stable schizophrenia(OR = 12.741, 95%CI:1.424 ~ 114.005, p = 0.023). The combined serum CysC, β2-MG, and UA test for cognitive function in stable schizophrenia inpatients had an AUC area of 0.71, with a sensitivity and specificity of 79.5% and 60.5%, respectively, and a predictive value superior to that of an independent diagnosis. Conclusion In hospitalized patients with stable schizophrenia, serum CysC levels are positively correlated with the severity of cognitive impairment, particularly showing significant associations with information processing speed and executive function. CysC may be a risk factor for exacerbating cognitive impairment in these patients. The combined diagnostic value of serum CysC, β2-MG, and UA demonstrated moderate accuracy in identifying stable schizophrenia cognitive impairment. These data support the potential of CysC as a biomarker of cognitive function in stable schizophrenia.Keywords
All Related Versions
- Version 1, 2025-04-21, Research Square
- Published version: BMC Psychiatry, 25 (1), 494.
This publication has 75 references indexed in Scilit:
- High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosisJournal of Neurology, 2023
- Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort StudyClinical Therapeutics, 2023
- The percentage and clinical correlates of alexithymia in stable patients with schizophreniaEuropean Archives of Psychiatry and Clinical Neuroscience, 2022
- The Course of General Cognitive Ability in Individuals With Psychotic DisordersJAMA Psychiatry, 2022
- To Adjust or Not to Adjust: The Role of Different Covariates in Cardiovascular Observational StudiesAmerican Heart Journal, 2021
- Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with PharmacogeneticsAdvances in Therapy, 2020
- Long-term Changes in Cognitive Functioning in Individuals With Psychotic DisordersJAMA Psychiatry, 2020
- Schizophrenia—An OverviewJAMA Psychiatry, 2020
- Association between serum uric acid levels and coronary artery disease in different age and gender: a cross-sectional studyAging Clinical and Experimental Research, 2019
- Cystatin C is an Independent Risk Factor and Therapeutic Target for Acute Ischemic StrokeNeurotoxicity Research, 2015